European Union - English - EMA (European Medicines Agency)

krka, d.d., novo mesto - irbesartan hydrochloride - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - irbesartan - tablet - 75mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - irbesartan - tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - irbesartan - tablet - 300mg

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - irbesartan - film-coated tablet - 75 milligram(s) - angiotensin ii antagonists, plain; irbesartan

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - irbesartan - film-coated tablet - 150 milligram(s) - angiotensin ii antagonists, plain; irbesartan

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - irbesartan - film-coated tablet - 300 milligram(s) - angiotensin ii antagonists, plain; irbesartan

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - irbesartan - film coated tablet - 150 milligram - irbesartan

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - irbesartan - film coated tablet - 75 milligram - irbesartan

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - irbesartan - film coated tablet - 300 milligram - irbesartan